| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide mutations of an epidermal growth factor receptor (EGFr) and a mutant EGFr polypeptide. <P>SOLUTION: Mutations of the epidermal growth factor receptor (EGFr), of phosphatidylinositol 3'-kinase ("Pl3K"), and of B-Raf are described. Methods of treating tumors containing mutated EGFr with human monoclonal antibodies against EGFr are described. Methods and kits for ascertaining the presence of one or more mutant EGFr, mutant PI3K, and/or mutant B-Raf in a sample and for treating disorders or conditions related to the presence of mutant EGFr, mutant PI3K, and/or mutant B-Raf are also described. Methods of treating tumors containing mutant EGFr, mutant PI3K, and/or mutant B-Raf are also described. <P>COPYRIGHT: (C)2012,JPO&INPIT |
